Segment and Geographical Information (Tables)

6 Months Ended

Mar. 31, 2017

Segment Reporting [Abstract]

Segment Revenue, Operating Income and Depreciation and Amortization

The tables below present segment revenue, operating income and depreciation and amortization, as follows:

	Three Months Ended						Six Months Ended
	March 31,						March 31,
(Dollars in thousands)	2017			2016			2017			2016
Revenue:
Medical Device	$	12,726		$	11,599		$	26,482		$	23,846
In Vitro Diagnostics		4,777			5,100			8,782			9,394
Total revenue	$	17,503		$	16,699		$	35,264		$	33,240
Operating income:
Medical Device	$	1,504		$	2,322		$	5,223		$	6,152
In Vitro Diagnostics		2,236			1,982			3,692			3,625
Total segment operating income		3,740			4,304			8,915			9,777
Corporate		(2,063	)		(2,064	)		(3,970	)		(3,598	)
Total operating income	$	1,677		$	2,240		$	4,945		$	6,179
Depreciation and amortization:
Medical Device	$	1,053		$	968		$	2,058		$	1,457
In Vitro Diagnostics		103			204			206			426
Corporate		172			215			346			414
Total depreciation and amortization	$	1,328		$	1,387		$	2,610		$	2,297